Nipro Management
Management criteria checks 2/4
Nipro's CEO is Yoshihiko Sano, appointed in May 2012, has a tenure of 13.42 years. directly owns 0.072% of the company’s shares, worth ¥180.66M. The average tenure of the management team and the board of directors is 10.8 years and 7.3 years respectively.
Key information
Yoshihiko Sano
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.4yrs |
| CEO ownership | 0.07% |
| Management average tenure | 10.8yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
CEO
Yoshihiko Sano (80 yo)
Mr. Yoshihiko Sano serves as President since May 2012 and Representative Director of Nipro Corporation since June 2000. Mr. Sano served as Managing Director of Nipro Corporation since June 2006 until May 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Board & President | 13.4yrs | no data | 0.072% ¥ 180.7m | |
| Manager of Accounting Department - Corporate Planning Division | 11.3yrs | no data | no data | |
| GM of General Affairs | 11.3yrs | no data | 0.016% ¥ 40.4m | |
| Executive MD of PharmaPackaging | 10.8yrs | no data | 0.011% ¥ 28.8m | |
| MD, Head of Regenerative Medicine and Business Promotion | 10.3yrs | no data | 0.019% ¥ 47.8m | |
| MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Director | 13yrs | no data | 0.0039% ¥ 9.9m | |
| MD, Head of Vascular Business Division & Director | no data | no data | 0.013% ¥ 32.7m | |
| Senior MD | no data | no data | 0.0048% ¥ 12.2m | |
| GM of Intn. Business | no data | no data | 0.0040% ¥ 10.1m | |
| Director & GM of International Business Division | less than a year | no data | 0.0095% ¥ 24.0m | |
| Director | less than a year | no data | no data | |
| Director & Head of Domestic Business Division | less than a year | no data | 0.0013% ¥ 3.2m |
Experienced Management: 8086's management team is seasoned and experienced (10.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Board & President | 25.3yrs | no data | 0.072% ¥ 180.7m | |
| GM of General Affairs | 16.3yrs | no data | 0.016% ¥ 40.4m | |
| Executive MD of PharmaPackaging | no data | no data | 0.011% ¥ 28.8m | |
| MD, Head of Regenerative Medicine and Business Promotion | 16.3yrs | no data | 0.019% ¥ 47.8m | |
| MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Director | no data | no data | 0.0039% ¥ 9.9m | |
| MD, Head of Vascular Business Division & Director | no data | no data | 0.013% ¥ 32.7m | |
| Senior MD | 19.1yrs | no data | 0.0048% ¥ 12.2m | |
| GM of Intn. Business | 7.3yrs | no data | 0.0040% ¥ 10.1m | |
| Director & GM of International Business Division | less than a year | no data | 0.0095% ¥ 24.0m | |
| Director | less than a year | no data | no data | |
| Director & Head of Domestic Business Division | less than a year | no data | 0.0013% ¥ 3.2m | |
| Director of Hua-Ma Packaging Business Division & Director | less than a year | no data | 0.0017% ¥ 4.3m |
Experienced Board: 8086's board of directors are considered experienced (7.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/24 09:32 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nipro Corporation is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Masahiro Nakanomyo | Barclays |
| Yuki Yamazaki | Daiwa Securities Co. Ltd. |
| Stephen Barker | Jefferies LLC |